α1D Adrenergic Receptor, Santa Cruz Biotechnology, sc-10721
What do reviewers generally think about sc-10721 from Santa Cruz Biotechnology?
Researchers report poor performance for sc-10721. In Western blotting of mouse brain and heart with knockout controls, it failed to detect a target-specific band. One reviewer points out that immunohistochemistry of ureter and stomach gave distinct staining, yet Western blotting of CHO cells stably expressing the receptor showed no signal difference versus nonexpressing lysates, leading to a conclusion of no specificity. Overall consensus is that the antibody lacks reliable target specificity for Western blotting, despite some IHC staining.
Information about this antibody
Vendor notes
User Reviews (2)
Review of: α1D Adrenergic Receptor, Santa Cruz Biotechnology, sc-10721 by Paul Simpson, UCSF
This antibody was included in a test of ten commercially available antibodies against alpha-1-adrenergic receptor subtypes. All antibodies were tested using Western blotting of brain and heart tissue from WT mice and knock out controls with genetic deletion of one, two or all three alpha-1-adrenergic receptor subtypes.
None of the antibodies detected a band of the appropriate size, or a band of larger or smaller size, that was present in WT mouse heart or brain and absent in KO heart or brain.
For further information see BC Jensen et al., 2009 (https://link.springer.com/article/10.1007%2Fs00210-008-0368-6)
Review of: α1D Adrenergic Receptor, Santa Cruz Biotechnology, sc-10721 by Wouter H. Lamers
The specificity of this antibody was evaluated in immunohistochemistry of murine ureteres and stomach tissue, as well as western blotting of lysed CHO cells.
Immunohistochemisry showed highly distinct staining patterns in rat ureter and stomach.
However, western blotting of cells stably expressing the α1D receptor in CHO cells showed no difference in signal compared to lysates of cells with no endogenous expression. Thus we conclude that this antibody has no specificity for the target antigen.
Dilutions:
WB: 1:400
IHC: 1:50
Ref: Pradidarcheep et al 2009. Lack of specificity of commercially available antisera
against muscarinergic and adrenergic receptors
https://www.ncbi.nlm.nih.gov/pubmed/?term=19198807
Comments